During the past decade, Spitalul Clinic Colentina conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 25 clinical trials were completed, i.e. on average, 64.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 16 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Colentina" #1 sponsor was "Pfizer" with 7 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Takeda" with 5 trials sponsored and "Amgen" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic Colentina" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Colentina" are "Ulcerative Colitis" (10 trials), "Colitis, Ulcerative" (4 trials), "Crohn's Disease" (4 trials), "Acute Myeloid Leukemia" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Spitalul Clinic Colentina" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Colentina" are "Drug" (48 trials), "Biological" (3 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Etrolizumab" (4 trials), "Mirikizumab" (4 trials), "Rituximab" (4 trials) and "Bendamustine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Colentina" are 53 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Clinic Colentina". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Spitalul Clinic Colentina, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Colentina, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

Spitalul Clinic Colentina has several departments that took part in Clinical trials: "Spitalul Clinic Colentina - Sectia de Spitulal Clinic Colentina, Gastroenterologie" - 3 trials, "Spitalul Clinic Colentina, Hematologie" - 2 trials